David Loewenstein

David Loewenstein, Ph.D., A.B.P.P.
Professor, Department of Psychiatry & Behavioral Sciences
Director, Psychological Services and Neuropsychology Laboratory, Mount Sinai Medical Center.
MHHC 3204F

Dr. Loewenstein has a number of research interests centering on the early detection of early cognitive impairment in neurodegenerative and other brain disorders, development of novel cognitive and functional measures, examining relationships between neuropsychological measures and neuroimaging and other biomarkers of early Alzheimer’s disease. Further, Dr. Loewenstein and other investigators in his laboratory have been involved in developing cognitive and functional interventions for normal elderly patients as well as those with Alzheimer’s disease and related disorders.

Dr. Loewenstein is Director of Research and Neuropsychological Laboratories at The Wien Center for Alzheimer’s Disease and Memory Disorders at Mount Sinai Medical Center, Miami Beach, FL.
He is Principal Investigator on several large NIH and state funded grants and has a number of ongoing longitudinal investigations with new cognitive instruments developed in his laboratory. The Direct Assessment of Functional status Scale (DAFS) was one of the first performance-based scales for Alzheimer’s disease and has been translated into multiple languages. The Semantic Interference Test (SIT) and the Loewenstein- Acevedo Scales for Semantic Interference (LASSI) have shown considerable promise in the early detection and prediction of progression in patients with early Alzheimer’s disease and other neurodegenerative disorders.